\-\ Texto\\:\\ \ \(0\)\
\-\ rapid\\ weight\\ gain\\ \\(40\\-lbs\\ in\\ one\\ year\\)\\,\\ round\\ face\\,\\ stretch\\ marks\\,\\ facial\\ flushing\\.\\ \ \(0\)\
\-\ elevated\\ \\ diurnal\\ cortisol\\,\\ elevated\\ cortisol\\ and\\ acth\\ with\\ crh\\ stimulation\\ test\\.\ \(0\)\
\-\ venous\\ sampling\\ from\\ the\\ inferior\\ petrosal\\ sinus\\ reveals\\ a\\ pituitary\\ source\\ of\\ elevated\\ acth\\ levels\\.\ \(0\)\
\-\ the\\ patient\\ underwent\\ tss\\ surgery\\ and\\ the\\ microadenoma\\ was\\ removed\\.\\ the\\ postoperative\\ period\\ was\\ uneventful\\.\\ the\\ patient\\â\\€\\™s\\ cortisols\\ levels\\ are\\ monitored\\ in\\ a\\ regular\\ basis\\.\ \(0\)\
\-\ mr\\ imaging\\ of\\ the\\ pituitary\\ demonstrates\\ a\\ 4\\,3\\ x\\ 4\\,0\\ x\\ 4\\,0\\ \\ mm\\ hypoenhancing\\ lesion\\ in\\ the\\ midline\\ of\\ the\\ anterior\\ and\\ superior\\ portion\\ of\\ the\\ anterior\\ pituitary\\ lobe\\.\\ postsurgical\\ changes\\ are\\ noted\\ in\\ the\\ sphenoid\\ sinus\\ and\\ in\\ the\\ remaining\\ pituitary\\ gland\\.\\ the\\ findings\\ are\\ compatible\\ with\\ a\\ microadenoma\\.\ \(0\)\
\-\ acth\\-secreting\\ pituitary\\ microadenoma\ \(0\)\
\-\ differential\\ diagnosis\\:\ \(3\)\
\-\ rathke\\ cleft\\ cyst\ \(0\)\
\-\ pars\\ intermedia\\ cyst\ \(2\)\
\-\ postoperative\\ changes\ \(4\)\
\-\ pituitary\\ hyperplasia\ \(1\)\
\-\ a\\ 9\\ year\\-old\\ girl\\ with\\ a\\ history\\ of\\ cushing\\â\\€\\™s\\ disease\\ presents\\ with\\ persistent\\ hypercortisolemia\\.\\ she\\ is\\ s\\/p\\ transphenoidal\\ surgery\\ \\(tss\\)\\ for\\ pituitary\\ microadenoma\\ performed\\ seven\\ months\\ ago\\,\\ with\\ a\\ negative\\ pathology\\ report\\ for\\ microadenoma\\ at\\ that\\ time\\.\ \(0\)\
\-\ this\\ is\\ a\\ typical\\ case\\ of\\ a\\ acth\\-secreting\\ pituitary\\ microadenoma\\.\\ the\\ persistence\\ of\\ symptoms\\ and\\ elevated\\ cortisols\\-acth\\ levels\\ after\\ tss\\ lead\\ to\\ further\\ work\\ up\\ which\\ revealed\\ the\\ cause\\ of\\ cushing\\â\\€\\™s\\ syndrome\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ microadenoma\\:\\ 0\\.17493287700344348\ \(0\)\
\-\ pituitary\\:\\ 0\\.13207238993697223\ \(0\)\
\-\ tss\\:\\ 0\\.11650464877488764\ \(0\)\
\-\ 4\\,0\\:\\ 0\\.0776697658499251\ \(0\)\
\-\ acth\\-secreting\\:\\ 0\\.0776697658499251\ \(0\)\
\-\ acth\\:\\ 0\\.05738267251958108\ \(0\)\
\-\ cortisol\\:\\ 0\\.05654293525258263\ \(0\)\
\-\ cushing\\:\\ 0\\.05654293525258263\ \(0\)\
\-\ elevated\\:\\ 0\\.051089275090027544\ \(0\)\
\-\ levels\\:\\ 0\\.04661565717980568\ \(0\)\
\-\ 40\\-lbs\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ crh\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ cortisols\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ 4\\,3\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ \\-rathke\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ \\-pars\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ \\-pituitary\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ hypercortisolemia\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ cortisols\\-acth\\:\\ 0\\.03883488292496255\ \(0\)\
\-\ diurnal\\:\\ 0\\.03578137111632843\ \(0\)\
\-\ \\-postoperative\\:\\ 0\\.03578137111632843\ \(0\)\
\-\ \\â\\€\\™\\:\\ 0\\.03375365735214259\ \(0\)\
\-\ flushing\\:\\ 0\\.03272785930769431\ \(0\)\
\-\ petrosal\\:\\ 0\\.03272785930769431\ \(0\)\
\-\ hypoenhancing\\:\\ 0\\.03272785930769431\ \(0\)\
\-\ s\\:\\ 0\\.032389000005919655\ \(0\)\
\-\ stretch\\:\\ 0\\.03174484806842466\ \(0\)\
\-\ marks\\:\\ 0\\.030941669404134113\ \(0\)\
\-\ transphenoidal\\:\\ 0\\.029155479500573917\ \(0\)\
\-\ intermedia\\:\\ 0\\.02869133625979054\ \(0\)\
\-\ postsurgical\\:\\ 0\\.028271467626291315\ \(0\)\
\-\ sampling\\:\\ 0\\.027888157595499993\ \(0\)\
\-\ sinus\\:\\ 0\\.027534440261166856\ \(0\)\
\-\ gain\\:\\ 0\\.025422889807238218\ \(0\)\
\-\ persistence\\:\\ 0\\.025022133075054402\ \(0\)\
\-\ x\\:\\ 0\\.024837588857687026\ \(0\)\
\-\ uneventful\\:\\ 0\\.0243157777883796\ \(0\)\
\-\ seven\\:\\ 0\\.023567323881791946\ \(0\)\
\-\ stimulation\\:\\ 0\\.023431765914096996\ \(0\)\
\-\ monitored\\:\\ 0\\.022695844836285693\ \(0\)\
\-\ basis\\:\\ 0\\.0225843126425223\ \(0\)\
\-\ postoperative\\:\\ 0\\.021873880274257445\ \(0\)\
\-\ changes\\:\\ 0\\.021577515209119477\ \(0\)\
\-\ sphenoid\\:\\ 0\\.020947468781586254\ \(0\)\
\-\ compatible\\:\\ 0\\.020798122738962106\ \(0\)\
\-\ cyst\\:\\ 0\\.020232344810802667\ \(0\)\
\-\ source\\:\\ 0\\.01987424374785167\ \(0\)\
\-\ remaining\\:\\ 0\\.019586213971363335\ \(0\)\
\-\ anterior\\:\\ 0\\.01939024514328403\ \(0\)\
\-\ rapid\\:\\ 0\\.01901193283540191\ \(0\)\
\-\ hyperplasia\\:\\ 0\\.018547789594618534\ \(0\)\
\-\ face\\:\\ 0\\.018460553351023028\ \(0\)\
\-\ cleft\\:\\ 0\\.01837501112257765\ \(0\)\
\-\ surgery\\:\\ 0\\.018281930082469384\ \(0\)\
\-\ lead\\:\\ 0\\.01804854428489605\ \(0\)\
\-\ work\\:\\ 0\\.01763583290129551\ \(0\)\
\-\ period\\:\\ 0\\.017600162371636394\ \(0\)\
\-\ regular\\:\\ 0\\.017358242734649105\ \(0\)\
\-\ removed\\:\\ 0\\.016972131249808772\ \(0\)\
\-\ report\\:\\ 0\\.016850598401708203\ \(0\)\
\-\ facial\\:\\ 0\\.016368510996221587\ \(0\)\
\-\ round\\:\\ 0\\.016262354381335855\ \(0\)\
\-\ test\\:\\ 0\\.01608252180635676\ \(0\)\
\-\ gland\\:\\ 0\\.016032461195562422\ \(0\)\
\-\ s\\/p\\:\\ 0\\.015790351573180227\ \(0\)\
\-\ a\\:\\ 0\\.015724221217477585\ \(0\)\
\-\ 9\\:\\ 0\\.015560857688231322\ \(0\)\
\-\ pathology\\:\\ 0\\.015407041542388908\ \(0\)\
\-\ are\\:\\ 0\\.01539480888805641\ \(0\)\
\-\ typical\\:\\ 0\\.015094478828854615\ \(0\)\
\-\ persistent\\:\\ 0\\.01501474296258317\ \(0\)\
\-\ reveals\\:\\ 0\\.014727963657687328\ \(0\)\
\-\ midline\\:\\ 0\\.014564449723958242\ \(0\)\
\-\ ago\\:\\ 0\\.014012021236992286\ \(0\)\
\-\ mm\\:\\ 0\\.013842269413193858\ \(0\)\
\-\ year\\-old\\:\\ 0\\.013827156923780691\ \(0\)\
\-\ venous\\:\\ 0\\.013664253825802332\ \(0\)\
\-\ portion\\:\\ 0\\.013635271574269105\ \(0\)\
\-\ weight\\:\\ 0\\.013493153238506016\ \(0\)\
\-\ girl\\:\\ 0\\.013235142867796468\ \(0\)\
\-\ underwent\\:\\ 0\\.01291716315188643\ \(0\)\
\-\ inferior\\:\\ 0\\.012772318772506886\ \(0\)\
\-\ cause\\:\\ 0\\.012736839764546107\ \(0\)\
\-\ revealed\\:\\ 0\\.012081382774740499\ \(0\)\
\-\ superior\\:\\ 0\\.012020897343851065\ \(0\)\
\-\ further\\:\\ 0\\.01197111956740202\ \(0\)\
\-\ mr\\:\\ 0\\.01196123115394905\ \(0\)\
\-\ differential\\:\\ 0\\.011951364887017313\ \(0\)\
\-\ negative\\:\\ 0\\.011242820094162442\ \(0\)\
\-\ syndrome\\:\\ 0\\.010766108267553488\ \(0\)\
\-\ time\\:\\ 0\\.010632604525283317\ \(0\)\
\-\ she\\:\\ 0\\.010567339830194592\ \(0\)\
\-\ performed\\:\\ 0\\.010495939785142376\ \(0\)\
\-\ months\\:\\ 0\\.010281679712291046\ \(0\)\
\-\ one\\:\\ 0\\.010201459838372883\ \(0\)\
\-\ lobe\\:\\ 0\\.010129186554729226\ \(0\)\
\-\ up\\:\\ 0\\.01012267467424768\ \(0\)\
\-\ symptoms\\:\\ 0\\.009381750999551275\ \(0\)\
\-\ in\\:\\ 0\\.009281877315864646\ \(0\)\
\-\ noted\\:\\ 0\\.008922560301553277\ \(0\)\
\-\ imaging\\:\\ 0\\.008819708477777986\ \(0\)\
\-\ was\\:\\ 0\\.008707290944613982\ \(0\)\
\-\ diagnosis\\:\\ 0\\.008644138021059119\ \(0\)\
\-\ the\\:\\ 0\\.00852638760286679\ \(0\)\
\-\ case\\:\\ 0\\.008235702347432912\ \(0\)\
\-\ demonstrates\\:\\ 0\\.008223000888340028\ \(0\)\
\-\ findings\\:\\ 0\\.008012497514493216\ \(0\)\
\-\ after\\:\\ 0\\.007788551553344505\ \(0\)\
\-\ presents\\:\\ 0\\.007690062975805842\ \(0\)\
\-\ lesion\\:\\ 0\\.0076676441674028845\ \(0\)\
\-\ patient\\:\\ 0\\.007547065470628969\ \(0\)\
\-\ which\\:\\ 0\\.007027068666266735\ \(0\)\
\-\ that\\:\\ 0\\.0065021177469551696\ \(0\)\
\-\ for\\:\\ 0\\.006423860340464451\ \(0\)\
\-\ \\(\\:\\ 0\\.0063644204955406215\ \(0\)\
\-\ \\)\\:\\ 0\\.006286675701438812\ \(0\)\
\-\ disease\\:\\ 0\\.006153028815928213\ \(0\)\
\-\ \\,\\:\\ 0\\.005962776773508533\ \(0\)\
\-\ from\\:\\ 0\\.0055790119522212\ \(0\)\
\-\ history\\:\\ 0\\.00519918298549376\ \(0\)\
\-\ at\\:\\ 0\\.0051002782063067536\ \(0\)\
\-\ \\:\\:\\ 0\\.004979184211412622\ \(0\)\
\-\ is\\:\\ 0\\.004954103774314764\ \(0\)\
\-\ this\\:\\ 0\\.004234084640150366\ \(0\)\
\-\ year\\:\\ 0\\.0042119174857837656\ \(0\)\
\-\ of\\:\\ 0\\.004105860821074482\ \(0\)\
\-\ and\\:\\ 0\\.003964956073396883\ \(0\)\
\-\ with\\:\\ 0\\.002577184495372021\ \(0\)\
\-\ \\.\\:\\ 0\\.002033013080464765\ \(0\)\
\-\ to\\:\\ 0\\.0018813573059162391\ \(0\)\
